RFX1 and malignant colon neoplasm: Previously, we found that in colon cancer, RFX1 showed a negative trend in correlation with the expression of key chemokines (CXCL9 and CXCL10) that induce the recruitment of CD8+ T cells to the tumor microenvironment.